Tubb4B Tubulin Beta 4B Class Iia is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox .infobox-gene}}
| Property | Value |
|---|---|
| Gene Symbol | TUBB4B |
| Full Name | Tubulin Beta 4B Class IIa |
| Chromosomal Location | 9q34.3 |
| NCBI Gene ID | 10383 |
| OMIM ID | 191307 |
| Ensembl ID | ENSG00000144410 |
| UniProt ID | P68371 |
| Associated Diseases | Leukodystrophy, Cortical Malformations, Sensory Neuropathy, |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
TUBB4B encodes beta-tubulin isotype 4B, a structural component of microtubules. It is expressed predominantly in testis and brain tissue, with high expression in neurons and glial cells. As a member of the tubulin family, TUBB4B forms heterodimers with alpha-tubulin to create microtubule filaments that serve as the structural backbone of the eukaryotic cytoskeleton.
Microtubules are dynamic polymers that undergo continuous assembly and disassembly, a property essential for their cellular functions. TUBB4B contributes to:
TUBB4B exhibits tissue-specific expression patterns:
TUBB4B is a 444-amino acid protein with a molecular weight of approximately 50 kDa. The protein contains:
TUBB4B undergoes several important post-translational modifications:
TUBB4B mutations cause hypomorphic leukodystrophies characterized by:
The most common TUBB4B mutation (p.Arg2His) disrupts microtubule dynamics and impairs oligodendrocyte function, leading to defective myelination 1.
TUBB4B mutations are associated with:
These malformations result from disrupted microtubule function during cortical development 2.
TUBB4B-related neuropathies present with:
TUBB4B mutations in combination with ACBD5 cause a syndrome featuring:
Impaired microtubule function disrupts axonal transport, leading to:
Microtubule defects impair mitochondrial transport, resulting in:
Altered microtubule dynamics can contribute to protein aggregation in neurodegenerative diseases:
Drugs that stabilize microtubules are being investigated for TUBB4B-related disorders:
Future therapeutic approaches include:
TUBB4B interacts with numerous proteins:
| Partner Protein | Interaction Type | Function |
|---|---|---|
| TUBA1A | Polymerization partner | Forms α/β-tubulin heterodimers |
| MAP2 | Structural binding | Stabilizes neuronal microtubules |
| TAU | Co-regulation | Modulates microtubule assembly |
| Kinesin-1 | Motor binding | Enables intracellular transport |
| Dynein | Motor binding | Retrograde transport |
| Stathmin | Regulation | Destabilizes microtubules |
TUBB4B is an essential tubulin isotype critical for microtubule function in neurons and glia. Mutations cause leukodystrophy, cortical malformations, and sensory neuropathy through disrupted microtubule dynamics, impaired axonal transport, and defective myelination. Understanding TUBB4B function provides insights into microtubule-related neurodegenerative mechanisms and identifies potential therapeutic targets.
The study of Tubb4B Tubulin Beta 4B Class Iia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.